6 - 8 November 2017 - Glasgow, UK

Pope Woodhead will be attending exhibiting on booth number 306 at this year's ISPOR 20th Annual European Congress on the 6 - 8th November in Glasgow, Scotland. Several members of the Commercial team have actively engaged in thought leadership for this event and have successfully had six posters accepted for presentation.

Themes for our poster that have been accepted are as follows:

  • AN EVIDENCE-BASED APPROACH TO PREDICT LONG-TERM PATIENT OUTCOMES AND KEY VALUE DRIVERSAN EVIDENCE-BASED APPROACH TO PREDICT LONG-TERM PATIENT OUTCOMES AND KEY VALUE DRIVERS

  • ASSESSING COST-EFFECTIVENESS AND KEY VALUE DRIVERS OF ADJUVANT TRIGLYCERIDE LOWERING THERAPY IN MANAGEMENT OF PATIENTS WITH A RARE GENETIC SYNDROME

  • IMPACT OF MULTI-DRUG RESISTANCE ON HTA ASSESSMENT OF ANTIBIOTICS IN FRANCE, GERMANY, UNITED KINGDOM

  • UNDERSTANDING HEALTH TECHNOLOGY ASSESSMENT OUTCOMES FOR PRODUCTS WITH CONDITIONAL MARKET AUTHORISATION IN FRANCE: INITIAL EVALUATION VS. RE-ASSESSMENT

  • MARKET ACCESS OF ADVANCED THERAPY MEDICINAL PRODUCT (ATMP) IN EUROPE: LESSONS LEARNT AND KEY CONSIDERATIONS FOR FUTURE SUCCESS

  • A CONCEPTUAL YET PRAGMATIC FRAMEWORK FOR VALUE-BASED AGREEMENTS

Share